What infections can cross-react with the Filaria Antibody (FILARIA AB) Immunoglobulin G4 (IgG4) lab test and which specific autoimmune disorders should be included in the differential diagnosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differential Diagnosis for Cross-Reaction with Quest Diagnostics FILARIA AB IGG4 Lab Test

The Quest Diagnostics FILARIA AB IGG4 lab test is designed to detect antibodies against filarial parasites, which cause diseases like lymphatic filariasis. However, due to cross-reactivity, other infections and autoimmune disorders might yield false-positive results. Here's a categorized differential diagnosis:

  • Single Most Likely Diagnosis
    • Loiasis: Caused by the Loa loa parasite, this infection can cross-react with filarial antibody tests due to antigenic similarities. Loiasis is prevalent in Central and West Africa, and its symptoms can overlap with those of filariasis, making it a likely candidate for cross-reactivity.
  • Other Likely Diagnoses
    • Toxocariasis: Infection with Toxocara species, commonly found in dogs and cats, can lead to cross-reactivity due to similar epitopes. This parasitic infection is widespread and can cause visceral or ocular larva migrans.
    • Strongyloidiasis: Strongyloides stercoralis infection can also cross-react with filarial antibody tests. This parasitic infection is common in tropical and subtropical regions and can cause a range of symptoms from asymptomatic to severe gastrointestinal and respiratory issues.
    • Onchocerciasis: Although Onchocerca volvulus is a filarial parasite, the test might not specifically distinguish between different filarial species, leading to potential cross-reactivity. Onchocerciasis, or river blindness, is a significant public health problem in sub-Saharan Africa.
  • Do Not Miss Diagnoses
    • Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): This autoimmune disorder can present with elevated eosinophils and might cross-react with the FILARIA AB IGG4 test. Although rare, missing this diagnosis could lead to severe consequences due to its potential for organ damage.
    • Tropical Pulmonary Eosinophilia (TPE): A condition characterized by marked eosinophilia and pulmonary symptoms, TPE can be mistaken for filariasis due to cross-reactivity. It's crucial to differentiate TPE from filariasis, as treatment approaches differ significantly.
  • Rare Diagnoses
    • Idiopathic Hypereosinophilic Syndrome (HES): A group of disorders characterized by persistent eosinophilia without a known cause, HES could potentially cross-react with the FILARIA AB IGG4 test. The diagnosis of HES is one of exclusion, making it challenging but important to consider in the differential.
    • Autoimmune Lymphoproliferative Syndrome (ALPS): Although extremely rare, ALPS can present with lymphadenopathy, splenomegaly, and elevated eosinophils, potentially leading to cross-reactivity with the filarial antibody test. The importance of not missing ALPS lies in its potential for severe immune dysregulation and malignancy risk.

Each of these diagnoses has a unique set of clinical presentations, epidemiological factors, and laboratory findings that can help in differentiating them from true filarial infections. A thorough clinical evaluation, travel history, and additional diagnostic tests are essential for accurate diagnosis and appropriate management.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.